Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04942717 · ClinicalTrials.gov registry record · NA

Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values

A NA study of Solid Tumor and Solid Tumor, Adult, sponsored by Memorial Sloan Kettering Cancer Center.

Recruiting
Registry status
NA
Development phase
234
Enrollment target
5
Study locations

NCT04942717: Recruiting NA study of Solid Tumor and Solid Tumor, Adult, sponsored by Memorial Sloan Kettering Cancer Center.

NCT04942717 is a NA study of Solid Tumor and Solid Tumor, Adult that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 234 participants, roughly in line with the 220-participant average among 196 other Solid Tumor trials with a reported enrollment target. The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04942717, a NA study of Solid Tumor and Solid Tumor, Adult, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.

RECRUITING
Registry status
NA
Development phase
234 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this study is to translate and tailor for Latinx participants a program called Communicating with Oncology Nurses about Values from the Outset (CONVO). In CONVO, routine cancer care for each participant includes a discussion between the nurse and participant about the participant's health-related values.

Primary Outcome

To translate/transcreate (linguistic plus cultural adaptation) our intervention for implementation with Spanish-speaking Latinx cancer patients receiving outpatient oncologic care in their communities: Comunicar Nuestros Valores a las enfermeras de Oncología desde el comienzo del tratamiento de cáncer.

Interventions

  • BEHAVIORAL CONVO intervention

Study Locations (5)

New York

  • MSK at Ralph Lauren (All Protocol Activities) - New York
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
  • SBH Health System - The Bronx
  • Jacobi Medical Center - The Bronx
  • New York Cancer & Blood Specialists (Data collection only) - The Bronx

Trial Details

FieldValue
Enrollment Target 234 participants
Start Date 2021-06-18
Est. Completion 2026-06-18
Phase NA
Memorial Sloan Kettering Cancer Center

1,884 total trials

What NCT04942717 shows while recruiting

NCT04942717 is an interventional study that assigns participants to a tested intervention. The registered 234 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 220-participant average among 196 other Solid Tumor trials with a reported enrollment target.

The record links to 3 conditions, with Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which CONVO intervention is the first listed.

NCT04942717 lists 5 locations in 1 state (New York).

Frequently Asked Questions

What is clinical trial NCT04942717 about?

NCT04942717 is a clinical study titled "Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values". The purpose of this study is to translate and tailor for Latinx participants a program called Communicating with Oncology Nurses about Values from the Outset (CONVO). In CONVO, routine cancer care for each participant includes a discussion between the nurse and participant about the participant's he...

What is the current status of trial NCT04942717?

This trial is currently recruiting. It is a NA study. The enrollment target is 234 participants. The study started on 2021-06-18. Estimated completion is 2026-06-18.

What conditions does trial NCT04942717 study?

This clinical trial studies the following conditions: Solid Tumor, Solid Tumor, Adult, Solid Tumor, Unspecified, Adult.

What interventions are being tested in trial NCT04942717?

The interventions under investigation include: CONVO intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04942717?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04942717 being conducted?

This trial has 5 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04942717's enrollment target sits among peer trials

234 29th of 196 higher than 168 of 196 other Solid Tumor trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Solid Tumor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05208671 · 234 participants · NA

    Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma

  • NCT05444465 · 234 participants · NA

    Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears

  • NCT05720338 · 234 participants · Phase 3

    Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?

  • NCT06047301 · 234 participants · NA

    Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04942717, the US trial registry maintained by the National Library of Medicine. NCT04942717 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.